Jacobs Levy Equity Management
RCEL icon

Jacobs Levy Equity Management’s Avita Medical RCEL Stock Holding History

Jacobs Levy Equity Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-138,199
Closed -$731K – 1093
2025
Q2 		$731K Buy
138,199
+92,226
+201% +$671K ﹤0.01% 818
2025
Q1 		$374K Buy
+45,973
New +$430K ﹤0.01% 954

Other funds holding RCEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Jacobs Levy Equity Management's RCEL Position: Q3 2025 in Review

Jacobs Levy Equity Management sold out of Avita Medical (RCEL) in Q3 2025, closing a stake of 138,199 shares — an estimated $731K sold.

Jacobs Levy Equity Management first reported a position in RCEL in Q1 2025 and held it in 2 quarters. The position peaked at $731K in Q2 2025. 76 funds tracked by Wall St. Rank hold RCEL as of Q3 2025.

  • Jacobs Levy Equity Management reported no remaining Avita Medical position as of Q3 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 138,199 Avita Medical shares in Q3 2025, an estimated $731K.
  • Jacobs Levy Equity Management first reported a position in Avita Medical in Q1 2025 and held it in 2 quarters.
  • Jacobs Levy Equity Management's Avita Medical position peaked at $731K in Q2 2025.
  • 76 funds tracked by Wall St. Rank held Avita Medical as of Q3 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.